BP000176-CYT-401: Recombinant Porcine Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
The ED50 is 15-30 ng/ml corresponding to a Specific Activity of 33,334-66,667 IU/mg, determined by the dose dependent proliferation of TF-1 cells.
Purity: > 95% by RP-HPLC and SDS-PAGE.BP000176-CYT-720: Recombinant Rhesus Macaque Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is < 0.1 ng/ml, corresponding to a Specific Activity of 10,000,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000176-GD19: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is less then 0.1 ng/ml, corresponding to a Specific Activity of 1.0 x 10^7 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.01 ng/ug (0.1 IEU/ug).C058P: Ibalizumab Biosimilar, Human CD4 Monoclonal Antibody
Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody ibalizumab biosimilar specifically binds to the human CD4 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ibalizumab.